These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14970909)

  • 1. An engineered PrPsc-like molecule from the chimera of mammalian prion protein and yeast Ure2p prion-inducing domain.
    Yin SM; Sy MS; Po T
    Acta Biochim Biophys Sin (Shanghai); 2004 Feb; 36(2):128-32. PubMed ID: 14970909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prion domain of yeast Ure2p induces autocatalytic formation of amyloid fibers by a recombinant fusion protein.
    Schlumpberger M; Wille H; Baldwin MA; Butler DA; Herskowitz I; Prusiner SB
    Protein Sci; 2000 Mar; 9(3):440-51. PubMed ID: 10752606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural characterization of the fibrillar form of the yeast Saccharomyces cerevisiae prion Ure2p.
    Bousset L; Redeker V; Decottignies P; Dubois S; Le Maréchal P; Melki R
    Biochemistry; 2004 May; 43(17):5022-32. PubMed ID: 15109261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The [URE3] yeast prion results from protein aggregates that differ from amyloid filaments formed in vitro.
    Ripaud L; Maillet L; Immel-Torterotot F; Durand F; Cullin C
    J Biol Chem; 2004 Dec; 279(49):50962-8. PubMed ID: 15456789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The native-like conformation of Ure2p in fibrils assembled under physiologically relevant conditions switches to an amyloid-like conformation upon heat-treatment of the fibrils.
    Bousset L; Briki F; Doucet J; Melki R
    J Struct Biol; 2003 Feb; 141(2):132-42. PubMed ID: 12615539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of inactivation on prion conversion of the Saccharomyces cerevisiae Ure2 protein.
    Baxa U; Speransky V; Steven AC; Wickner RB
    Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5253-60. PubMed ID: 11959975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autocatalytic conversion of recombinant prion proteins displays a species barrier.
    Baskakov IV
    J Biol Chem; 2004 Feb; 279(9):7671-7. PubMed ID: 14668351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrogen/deuterium exchange mass spectrometry identifies two highly protected regions in recombinant full-length prion protein amyloid fibrils.
    Nazabal A; Hornemann S; Aguzzi A; Zenobi R
    J Mass Spectrom; 2009 Jun; 44(6):965-77. PubMed ID: 19283723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of oligomeric species in the fibrillization pathway of the yeast prion Ure2p.
    Catharino S; Buchner J; Walter S
    Biol Chem; 2005 Jul; 386(7):633-41. PubMed ID: 16207084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid interaction converts prion protein to a PrPSc-like proteinase K-resistant conformation under physiological conditions.
    Wang F; Yang F; Hu Y; Wang X; Wang X; Jin C; Ma J
    Biochemistry; 2007 Jun; 46(23):7045-53. PubMed ID: 17503780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annealing prion protein amyloid fibrils at high temperature results in extension of a proteinase K-resistant core.
    Bocharova OV; Makarava N; Breydo L; Anderson M; Salnikov VV; Baskakov IV
    J Biol Chem; 2006 Jan; 281(4):2373-9. PubMed ID: 16314415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggregation and fibrillization of the recombinant human prion protein huPrP90-231.
    Swietnicki W; Morillas M; Chen SG; Gambetti P; Surewicz WK
    Biochemistry; 2000 Jan; 39(2):424-31. PubMed ID: 10631004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).
    Bocharova OV; Breydo L; Parfenov AS; Salnikov VV; Baskakov IV
    J Mol Biol; 2005 Feb; 346(2):645-59. PubMed ID: 15670611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations.
    Jackson GS; Hosszu LL; Power A; Hill AF; Kenney J; Saibil H; Craven CJ; Waltho JP; Clarke AR; Collinge J
    Science; 1999 Mar; 283(5409):1935-7. PubMed ID: 10082469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro self-propagation of recombinant PrPSc-like conformation generated in the yeast cytoplasm.
    Yang W; Yang H; Tien P
    FEBS Lett; 2006 Jul; 580(17):4231-5. PubMed ID: 16831424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assemblages of prion fragments: novel model systems for understanding amyloid toxicity.
    Satheeshkumar KS; Murali J; Jayakumar R
    J Struct Biol; 2004 Nov; 148(2):176-93. PubMed ID: 15477098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimized overproduction, purification, characterization and high-pressure sensitivity of the prion protein in the native (PrP(C)-like) or amyloid (PrP(Sc)-like) conformation.
    Alvarez-Martinez MT; Torrent J; Lange R; Verdier JM; Balny C; Liautard JP
    Biochim Biophys Acta; 2003 Feb; 1645(2):228-40. PubMed ID: 12573253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High pressure induces scrapie-like prion protein misfolding and amyloid fibril formation.
    Torrent J; Alvarez-Martinez MT; Harricane MC; Heitz F; Liautard JP; Balny C; Lange R
    Biochemistry; 2004 Jun; 43(22):7162-70. PubMed ID: 15170353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion domain initiation of amyloid formation in vitro from native Ure2p.
    Taylor KL; Cheng N; Williams RW; Steven AC; Wickner RB
    Science; 1999 Feb; 283(5406):1339-43. PubMed ID: 10037606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How does domain replacement affect fibril formation of the rabbit/human prion proteins.
    Yan X; Huang JJ; Zhou Z; Chen J; Liang Y
    PLoS One; 2014; 9(11):e113238. PubMed ID: 25401497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.